Edition:
United States

Insider Trading: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

58.56USD
25 Jul 2016
Change (% chg)

$-0.26 (-0.44%)
Prev Close
$58.82
Open
$58.88
Day's High
$58.88
Day's Low
$57.99
Volume
2,295,763
Avg. Vol
2,807,671
52-wk High
$60.06
52-wk Low
$45.70

All Insider Trades
Trading Date Name Title Type Shares Traded Price
5 May 2016

Ambrose Adele D

Officer Sell 1,243 $54.09
13 Apr 2016

Frazier (Kenneth C)

Chief Executive Officer Buy 131,040 $44.19
13 Apr 2016

Frazier (Kenneth C)

Chief Executive Officer Sell 131,040 $56.11
12 Apr 2016

Harrison (William B Jr)

Director Buy 5,000 $34.44
21 Feb 2016

Holston Michael J

General Counsel Buy 11,443 $50.77
21 Feb 2016

Graddick-Weir (Mirian M)

Officer Buy 16,326 $50.77
21 Feb 2016

Frazier (Kenneth C)

Chief Executive Officer Buy 93,241 $50.77
21 Feb 2016

Deese (Willie A)

Officer Buy 14,557 $50.77
21 Feb 2016

Perlmutter (Roger M)

Officer Buy 25,227 $50.77
21 Feb 2016

Golestani (Clark)

Chief Technology Officer Buy 6,150 $50.77
21 Feb 2016

Gerberding (Julie L)

Officer Buy 3,377 $50.77
21 Feb 2016

Ambrose Adele D

Officer Buy 2,537 $50.77
21 Feb 2016

Rosenblatt Michael

Officer Buy 7,738 $50.77
21 Feb 2016

Deluca Richard R Jr

Officer Buy 11,332 $50.77
21 Feb 2016

Schechter (Adam H)

Officer Buy 37,223 $50.77
3 Nov 2015

Weeks (Wendell P)

Director Sell 5,000 $55.53
3 Nov 2015

Weeks (Wendell P)

Director Buy 5,000 $34.44
2 Nov 2015

Frazier (Kenneth C)

Chief Executive Officer Gift 9,000 $0.00
28 Oct 2015

Frazier (Kenneth C)

Chief Executive Officer Sell 18,666 $54.69
28 Oct 2015

Ambrose Adele D

Officer Buy 37,313 $36.56
28 Oct 2015

Frazier (Kenneth C)

Chief Executive Officer Buy 18,666 $35.09
28 Oct 2015

Ambrose Adele D

Officer Sell 37,313 $55.08
27 Oct 2015

Wendell (Peter C)

Director Buy 5,000 $34.44
27 Oct 2015

Wendell (Peter C)

Director Sell 5,000 $54.85
31 Jul 2015

Holston Michael J

General Counsel Buy 22,584 $0.00

Institutional Holders

% Shares Owned: 74.85%
# of Holders: 2,243
Total Shares Held: 2,071,968,223
3 Mo. Net Change: 738,776
# New Positions: 21
# Closed Positions: 6
# Increased Positions: 203
# Reduced Positions: 189
# Net Buyers: 14

Officers & Directors

Name Age Since Current Position

Kenneth Frazier

61 2011 Chairman of the Board, President, Chief Executive Officer

Robert Davis

49 2014 Chief Financial Officer, Executive Vice President

Clark Golestani

49 2012 Executive Vice President, Chief Information Officer

Michael Holston

53 2015 Executive Vice President, General Counsel

Mirian Graddick-Weir

61 2009 Executive Vice President - Human Resources

Sanat Chattopadhyay

2016 Executive Vice President and President - Merck Manufacturing Division

Richard DeLuca

53 2011 Executive Vice President, President - Merck Animal Health

Julie Gerberding

60 2015 Executive Vice President - Strategic Communications, Global Public Policy & Population Health

Roger Perlmutter

64 2013 Executive Vice President, President - Merck Research Laboratories

Michael Rosenblatt

68 2009 Executive Vice President, Chief Medical Officer

Adam Schechter

51 2010 Executive Vice President, President - Global Human Health

Rita Karachun

52 2014 Senior Vice President Finance - Global Controller

Adele Ambrose

59 2009 Senior Vice President, Chief Communications Officer

Leslie Brun

63 2016 Lead Independent Director

Thomas Cech

69 2009 Independent Director

Pamela Craig

59 2015 Independent Director

Thomas Glocer

56 2007 Independent Director

C. Robert Kidder

71 2005 Independent Director

Rochelle Lazarus

68 2004 Independent Director

Carlos Represas

71 2009 Independent Director

Paul Rothman

58 2015 Independent Director

Patricia Russo

64 1995 Independent Director

Craig Thompson

63 2008 Independent Director

Wendell Weeks

56 2004 Independent Director

Peter Wendell

65 2003 Independent Director

Joseph Romanelli

2015 IR Contact Officer